About Syngenit Surgical

Syngenit Surgical is a single surgery used to regenerate damaged articular cartilage. The procedure uses your own bone marrow stem cells and your own blood as a glue. This technology has been in clinical use for many years.

 

The procedure takes place under a general anaesthetic. Bone marrow will be taken and the bone marrow stem cells concentrated using a machine in the operating room. Following the removal of any damaged cartilage, the concentrated cells will be placed onto a pad and placed into the area prepared by the surgeon. The pad will be held in place by a biological glue which is made in the operating theatre from your own blood.

Procedure Overview (Knee Cartilage)

The osteochondral defect is identified prior to the surgery using Magnetic Resonance Imaging (MRI). An arthroscopic procedure may also be used to verify the defect is suitable for this treatment.

Bone marrow aspirate is harvested from the patient and used to produce bone marrow aspirate concentrate which contains the stem cells. 


 

The surgeon will prepare the cartilage defect. The bone marrow aspirate concentrate is applied to a pad.

 

 

 

 

 

The pad containing the stem cells is placed into the cartilage defect and secured using a glue derived from the patient’s blood. The glue is also prepared in the operating room.

Syngenit Surgical Patient Leaflet

Syngenit Surgical Patient Leaflet_Knee_R[...]
Adobe Acrobat document [287.0 KB]
Syngenit Surgical Patient Leaflet_Hip_Re[...]
Adobe Acrobat document [842.4 KB]
Syngenit Surgical Patient Leaflet_Ankle_[...]
Adobe Acrobat document [710.8 KB]
Syngenit Surgical Patient Leaflet_Spinal[...]
Adobe Acrobat document [388.0 KB]
Print | Sitemap
Syngenit is a registered trademark with the UK patent office (UK00003298478) All rights reserved